Ace Therapeutics Press Releases

• Published on June 5, 2025 - 08:24 GMT

  Ace Therapeutics Releases Custom Models to Empower Alzheimer's Disease Research

  Ace Therapeutics has unveiled a suite of customizable in vivo and in vitro models designed to accelerate Alzheimer's disease (AD) drug development. NEW YORK, NY, UNITED STATES, June 5, 2025 /⁨EINPresswire.com⁩/ -- Ace Therapeutics, a leading innovator …

  Distribution channels: Business & Economy, Companies ...
• Published on May 23, 2025 - 06:57 GMT

  Ace Therapeutics Launches Validated Disease Models Aiming to Elevate Gastroenterology Research to New Heights

  Ace Therapeutics recently unveiled a comprehensive suite of well-validated disease models tailored for gastroenterology lab research. NEW YORK, NY, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Ace Therapeutics, a preclinical contract research …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on May 15, 2025 - 05:52 GMT

  Empowering IBD Research: Ace Therapeutics Releases Customized IBD Animal Models

  Ace Therapeutics released its customized IBD animal models developed to address the complex challenges of IBD drug discovery and therapeutic development. NEW YORK, NY, UNITED STATES, May 15, 2025 /⁨EINPresswire.com⁩/ -- Ace Therapeutics, a leading IBD …

  Distribution channels: Business & Economy, Companies ...
• Published on April 3, 2025 - 04:08 GMT

  Ace Therapeutics Unveils Advanced Animal Models to Unlock Breakthroughs in Diabetic Wound Healing

  NEW YORK, NY, UNITED STATES, April 3, 2025 /⁨EINPresswire.com⁩/ -- Ace Therapeutics is a service provider providing integrated solutions for innovative drug development in the preclinical stage of diabetes mellitus (DM) and its complications. Recently, the …

  Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
• Published on November 29, 2024 - 08:08 GMT

  Ace Therapeutics Unveils Custom In Vivo Ocular Modeling Services to Power Up Ophthalmology Research

  To accelerate ophthalmology research and enhance discovery of therapeutic interventions, Ace Therapeutics announced its custom in vivo ocular modeling services. NEW YORK, NY, UNITED STATES, November 29, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics …

  Distribution channels: Business & Economy, Companies ...
• Published on September 27, 2024 - 10:45 GMT

  Ace Therapeutics Announces ADME/DMPK Services to Advance Stroke Drug Development

  Ace Therapeutics is excited to announce the expansion of its services with the addition of ADME/DMPK services to support stroke drug development. NEW YORK, NY, UNITED STATES, September 27, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics, one of the leading …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on August 27, 2024 - 09:15 GMT

  Ace Therapeutics Unveils Model Development Services to Power Up Psychiatric Drug R&D

  Ace Therapeutics has announced the launch of its model development services aiming at revolutionizing psychiatric drug research and development. NEW YORK, NY, USA, August 27, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics, a preclinical contract research …

  Distribution channels: Business & Economy, Companies ...
• Published on August 9, 2024 - 08:33 GMT

  Ace Therapeutics Unveils Next-Generation Drug Delivery Technologies for Glaucoma

  Ace Therapeutics is proud to announce the unveiling of its cutting-edge drug delivery system development services for the treatment of glaucoma. NEW YORK, NY, UNITED STATES, August 9, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics is a preclinical contract …

  Distribution channels: Business & Economy, Companies ...
• Published on July 30, 2024 - 10:16 GMT

  Rdcthera Releases RDC Development Services to Drive Forward Drug Research and Development

  Rdcthera announced today the release of its revolutionary RDC development services aimed at expediting the bioconjugation drug development process. NEW YORK, NY, USA, July 30, 2024 /⁨EINPresswire.com⁩/ -- Rdcthera, an expert in radionuclide drug conjugate …

  Distribution channels: Business & Economy, Companies ...
• Published on July 24, 2024 - 06:20 GMT

  Ace Therapeutics Accelerates Preclinical GI and Hepatology Research with Disease Model Customization Services

  Ace Therapeutics recently unveiled disease model customization services to accelerate further the preclinical research on gastroenterology (GI) and hepatology. NEW YORK, NY, UNITED STATES, July 24, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics is a …

  Distribution channels: Business & Economy, Companies ...
• Published on July 5, 2024 - 08:17 GMT

  Ace Therapeutics Announces Vaccine Development Services Against Superbugs

  With the rise of superbugs posing a significant threat to global public health, Ace Therapeutics announces vaccine development services to address this problem. NEW YORK, NY, UNITED STATES, July 5, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics is a …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...
• Published on June 20, 2024 - 07:04 GMT

  Ace Therapeutics Offers One-Stop Shop for Glaucoma In Vivo Study

  Ace Therapeutics is pleased to announce that it offers clients a comprehensive range of services for preclinical in vivo studies focused on glaucoma research. NEW YORK, NY, UNITED STATES, June 20, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics, a leading …

  Distribution channels: Business & Economy, Companies ...